Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atrayee Basu-Mallick

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Pancreatic Cancer|June 7, 2021
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer DiagnosisAmy E McGhee-Jez, Inna Chervoneva, Misung Yi, et al.
Cancer Genetics|September 28, 2021
TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumorsJu-Yoon Yoon, Wei Jiang, Christopher R Orr, et al.
The New England Journal of Medicine|November 22, 2023
Liver Transplantation in a Woman with Mahvash DiseaseJustin Robbins, Dina Halegoua-DeMarzio, Atrayee Basu Mallick, et al.
Radiation Oncology (London, England)|May 29, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinomaSpencer J Poiset, Sophia Shah, Louis Cappelli, et al.
JCO Precision Oncology|December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based TherapyIda Micaily, Edik M Blais, Randi Carhart, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
JCO Precision Oncology|July 2, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in ChordomaDaniel S Lefler, Andrew Elliott, Wei Jiang, et al.
JAMA Network Open|January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical TrialBrandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Pancreatic Cancer|June 7, 2021
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer DiagnosisAmy E McGhee-Jez, Inna Chervoneva, Misung Yi, et al.
Cancer Genetics|September 28, 2021
TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumorsJu-Yoon Yoon, Wei Jiang, Christopher R Orr, et al.
The New England Journal of Medicine|November 22, 2023
Liver Transplantation in a Woman with Mahvash DiseaseJustin Robbins, Dina Halegoua-DeMarzio, Atrayee Basu Mallick, et al.
Radiation Oncology (London, England)|May 29, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinomaSpencer J Poiset, Sophia Shah, Louis Cappelli, et al.
JCO Precision Oncology|December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based TherapyIda Micaily, Edik M Blais, Randi Carhart, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
JCO Precision Oncology|July 2, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in ChordomaDaniel S Lefler, Andrew Elliott, Wei Jiang, et al.
JAMA Network Open|January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical TrialBrandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
Cancer|September 28, 2023
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomasShivaani Kummar, Lin Shen, David S Hong, et al.
Pageof 3